176 related articles for article (PubMed ID: 31498469)
1. Association of the extent of therapy with prostate cancer in those receiving testosterone therapy in a US commercial insurance claims database.
Lopez DS; Huang D; Tsilidis KK; Khera M; Williams SB; Urban RJ; Panagiotou OA; Kuo YF; Baillargeon J; Farias A; Krause T
Clin Endocrinol (Oxf); 2019 Dec; 91(6):885-891. PubMed ID: 31498469
[TBL] [Abstract][Full Text] [Related]
2. The role of testosterone replacement therapy and statin use, and their combination, in prostate cancer.
Lopez DS; Huang D; Tsilidis KK; Canfield S; Khera M; Baillargeon JG; Kuo YF; Peek MK; Platz EA; Markides K
Cancer Causes Control; 2021 Sep; 32(9):965-976. PubMed ID: 34041642
[TBL] [Abstract][Full Text] [Related]
3. Trends in Testosterone Therapy use in Prostate Cancer Survivors in the United States.
Chen T; Li S; Eisenberg ML
J Sex Med; 2021 Aug; 18(8):1346-1353. PubMed ID: 34303630
[TBL] [Abstract][Full Text] [Related]
4. Topical Testosterone Therapy Adherence and Outcomes Among Men With Primary or Secondary Hypogonadism.
Grabner M; Hepp Z; Raval A; Tian F; Khera M
J Sex Med; 2018 Feb; 15(2):148-158. PubMed ID: 29425664
[TBL] [Abstract][Full Text] [Related]
5. Independent and Joint Effects of Testosterone Replacement Therapy and Statins use on the Risk of Prostate Cancer Among White, Black, and Hispanic Men.
Lopez DS; Polychronopoulou E; Tsilidis KK; Khera M; Su LJ; Fowke JH; Peek MK; Kuo YF; Markides K; Canfield S
Cancer Prev Res (Phila); 2021 Jul; 14(7):719-728. PubMed ID: 33879532
[TBL] [Abstract][Full Text] [Related]
6. Joint association of statins and testosterone replacement therapy with cardiovascular disease among older men with prostate cancer: SEER-Medicare 2007-2015.
Lopez DS; Kim H; Polychronopoulou E; Taha S; Tsilidis KK; Villasante-Tezanos A; Peek MK; Gilani S; Khera M; Baillargeon J; Kuo YF; Canfield S
Cancer Epidemiol; 2022 Aug; 79():102172. PubMed ID: 35523034
[TBL] [Abstract][Full Text] [Related]
7. Use of weight loss medications in relation with prostate, colorectal and male breast cancers among older men: SEER-Medicare 2007-2015.
Lopez DS; Kim H; Polychronopoulou E; Torres-Sanchez LE; Villasante-Tezanos A; Baillargeon J; Canfield S; Kuo YF
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8255-8265. PubMed ID: 37067547
[TBL] [Abstract][Full Text] [Related]
8. Endogenous and exogenous testosterone and prostate cancer: decreased-, increased- or null-risk?
Lopez DS; Advani S; Tsilidis KK; Wang R; Canfield S
Transl Androl Urol; 2017 Jun; 6(3):566-579. PubMed ID: 28725600
[TBL] [Abstract][Full Text] [Related]
9. Testosterone therapy in prostate cancer: is it still a controversy?
Bart AS; Van Hoof A; Badre-Hume R; Selvarajah J; Robillard K; Albala DM
Curr Opin Urol; 2022 Nov; 32(6):598-606. PubMed ID: 36081393
[TBL] [Abstract][Full Text] [Related]
10. Metformin and testosterone replacement therapy inversely associated with hormone-associated cancers (prostate, colorectal and male breast cancers) among older White and Black men.
Lopez DS; Malagaris I; Polychronopoulou E; Tsilidis KK; Milani SA; Kristen Peek M; Villasante-Tezanos A; Alzweri L; Baillargeon J; Kuo YF; Canfield S
Clin Endocrinol (Oxf); 2022 Dec; 97(6):792-803. PubMed ID: 35902376
[TBL] [Abstract][Full Text] [Related]
11. Safety of testosterone therapy in men with prostate cancer.
Morgentaler A; Caliber M
Expert Opin Drug Saf; 2019 Nov; 18(11):1065-1076. PubMed ID: 31495240
[No Abstract] [Full Text] [Related]
12. Controversies in Testosterone Therapy.
Twitchell DK; Pastuszak AW; Khera M
Sex Med Rev; 2021 Jan; 9(1):149-159. PubMed ID: 33309270
[TBL] [Abstract][Full Text] [Related]
13. Testosterone therapy in females is not associated with increased cardiovascular or breast cancer risk: a claims database analysis.
Agrawal P; Singh SM; Hsueh J; Grutman A; An C; Able C; Choi U; Kohn J; Clifton M; Kohn TP
J Sex Med; 2024 Apr; 21(5):414-419. PubMed ID: 38459625
[TBL] [Abstract][Full Text] [Related]
14. The Role of Testosterone Therapy in the Setting of Prostate Cancer.
Rodriguez KM; Pastuszak AW; Khera M
Curr Urol Rep; 2018 Jun; 19(8):67. PubMed ID: 29961247
[TBL] [Abstract][Full Text] [Related]
15. Testosterone Therapy in Relation to Prostate Cancer in a U.S. Commercial Insurance Claims Database.
Cook MB; Beachler DC; Parlett LE; Cochetti PT; Finkle WD; Lanes S; Hoover RN
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):236-245. PubMed ID: 31641011
[TBL] [Abstract][Full Text] [Related]
16. Association of Male Hypogonadism With Risk of Hospitalization for COVID-19.
Dhindsa S; Champion C; Deol E; Lui M; Campbell R; Newman J; Yeggalam A; Nadella S; Ahir V; Shrestha E; Kannampallil T; Diwan A
JAMA Netw Open; 2022 Sep; 5(9):e2229747. PubMed ID: 36053534
[TBL] [Abstract][Full Text] [Related]
17. Testosterone Replacement Therapy in Relation With Cardiovascular Disease in Cisgender Women and Transgender People.
Lopez DS; Mulla JS; El Haddad D; Tahashilder MI; Polychronopolou E; Baillargeon J; Kuo YF; Gilani S; Khalife WI
J Clin Endocrinol Metab; 2023 Nov; 108(12):e1515-e1523. PubMed ID: 37392459
[TBL] [Abstract][Full Text] [Related]
18. Is testosterone a friend or a foe of the prostate?
Jannini EA; Gravina GL; Morgentaler A; Morales A; Incrocci L; Hellstrom WJ
J Sex Med; 2011 Apr; 8(4):946-55. PubMed ID: 21457469
[TBL] [Abstract][Full Text] [Related]
19. Healthcare utilization and costs among patients with chronic migraine, episodic migraine, and tension-type headache enrolled in commercial insurance plans.
Shao Q; Rascati KL; Barner JC; Lawson KA; Sonawane KB; Rousseau JF
Headache; 2022 Feb; 62(2):141-158. PubMed ID: 35156215
[TBL] [Abstract][Full Text] [Related]
20. Long-term treatment with testosterone undecanoate injections in men with hypogonadism alleviates erectile dysfunction and reduces risk of major adverse cardiovascular events, prostate cancer, and mortality.
Saad F; Caliber M; Doros G; Haider KS; Haider A
Aging Male; 2020 Mar; 23(1):81-92. PubMed ID: 30782054
[No Abstract] [Full Text] [Related]
[Next] [New Search]
